Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine M Rankin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Case Reports in Oncological Medicine|May 19, 2012
Arterial emboli complicating Cisplatin therapyCampbell D Tait, Elaine M Rankin
Cell Cycle (Georgetown, Tex.)|December 6, 2003
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to deathMichelle Ferguson, M Gloria Luciani, Lee Finlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II studySanjiv S Agarwala, John M Kirkwood, Martin Gore, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2006
In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancerJean-Didier Marechal, Jinglei Yu, Simon Brown, et al.
Cough (London, England)|October 8, 2010
Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on coughAlex Molassiotis, Jaclyn A Smith, Mike I Bennett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2006
In silico prediction of drug binding to CYP2D6: identification of a new metabolite of metoclopramideJinglei Yu, Mark J I Paine, Jean-Didier Maréchal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer GroupsBerend J Slotman, Murielle E Mauer, Andrew Bottomley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancerIgnace Vergote, Neil J Finkler, James B Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann, Peter L Stern, Elaine M Rankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patientsRosalie M Luiten, Esther W M Kueter, Wolter Mooi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Case Reports in Oncological Medicine|May 19, 2012
Arterial emboli complicating Cisplatin therapyCampbell D Tait, Elaine M Rankin
Cell Cycle (Georgetown, Tex.)|December 6, 2003
The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to deathMichelle Ferguson, M Gloria Luciani, Lee Finlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II studySanjiv S Agarwala, John M Kirkwood, Martin Gore, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2006
In silico and in vitro screening for inhibition of cytochrome P450 CYP3A4 by comedications commonly used by patients with cancerJean-Didier Marechal, Jinglei Yu, Simon Brown, et al.
Cough (London, England)|October 8, 2010
Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on coughAlex Molassiotis, Jaclyn A Smith, Mike I Bennett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2006
In silico prediction of drug binding to CYP2D6: identification of a new metabolite of metoclopramideJinglei Yu, Mark J I Paine, Jean-Didier Maréchal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer GroupsBerend J Slotman, Murielle E Mauer, Andrew Bottomley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2010
Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancerIgnace Vergote, Neil J Finkler, James B Hall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann, Peter L Stern, Elaine M Rankin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patientsRosalie M Luiten, Esther W M Kueter, Wolter Mooi, et al.
Pageof 1